Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes: the TRIGR nested case–control ancillary study

Diabetologia(2020)10.1007/s00125-019-05077-4Source: DataRank Database

Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes: the TRIGR nested case–control ancillary study is a research paper published in Diabetologia (2020). On theSindex it has a DataRank of 1.4. It has been cited 39 times, with 32 citing works in its 1-hop citation network.

N/A

1.4DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access39 citations · 32 citing works in its network

Download PDF

Cite:

Linked data & code

refsnp nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT00179777

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 4.22)OA: hybridTopics (83)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 39%Citation Network 61%

Base Score Contribution

0.553

From this paper's citation signal

Citation Network Contribution

0.876

From 26 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 32 citers.

The role of vitamin D in the aetiology of type 1 diabetes
Diabetologia202011 citations8 referencesContributes 0.311
Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study
PLoS Medicine202194 citations51 referencesContributes 0.089
Effect of vitamin D supplementation on pancreatic β-cell destruction and type 1 diabetes
Chinese Medical Journal20206 citations28 referencesContributes 0.069
The Causes of Insulin Resistance in Type 1 Diabetes Mellitus: Is There a Place for Quaternary Prevention?
International Journal of Environmental Research and Public Health202067 citations61 referencesContributes 0.069
Free, bioavailable 25-hydroxyvitamin D levels and their association with diabetic ketoacidosis in children with type 1 diabetes at diagnosis
Frontiers in Endocrinology202210 citations40 referencesContributes 0.060

Authors (12)

Maija E. Miettinen ORCID,Sari Niinistö ORCID,Iris Erlund ORCID,David Cuthbertson ORCID,Anita Nucci ORCID

Live enrichment

PubMed:31912198 PMC:PMC7054378 OpenAlex:https://openalex.org/W2999842120

National Institutes of Health

Grant: HD042444, HD051997

Suomen Akatemia

Grant: 250114

Finnish Centre of Excellence in Molecular Systems Immunology and Physiology Research

the Commission of the European Communities, RTD programme Quality of Life and Management of Living Resources

Grant: QLK1-2002-00372

NICHD NIH HHS

Grant: U01 HD051997

NICHD NIH HHS

Grant: R01 HD051997

NICHD NIH HHS

Grant: U01 HD042444

NIH HHS

Grant: HD051997

NIH HHS

Grant: HD042444

National Institutes of Health

Grant: 4U01HD040364-13

Trial to Reduce IDDM in the Genetically at Risk -study

National Institutes of Health

Grant: 2R01HD051997-11

Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit

National Institutes of Health

Grant: 1DP3DK106918-01

Effect of early diet and virus infections on immune regulation and the development islet autoimmunity -Trial to Reduce IDDM in the Genetically at Risk (TRIGR)

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5U01HD042444-15

Trial to Reduce IDDM in the Genetically at Risk: A Nutritional primary prevention

Diabetes Fonds

National Institute of Diabetes and Digestive and Kidney Diseases

European Foundation for the Study of Diabetes

Finnish Diabetes Research Foundation

Canadian Institutes of Health Research

JDRF

Eunice Kennedy Shriver National Institute of Child Health and Human Development

FWCI

4.22

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1007/s00125-019-05077-4

publisherhttps://doi.org/10.1007/s00125-019-05077-4

publisherhttp://link.springer.com/content/pdf/10.1007/s00125-019-05077-4.pdf

publisherhttp://link.springer.com/article/10.1007/s00125-019-05077-4/fulltext.html

repositoryhttps://pubmed.ncbi.nlm.nih.gov/31912198

Fields of Study

Diabetes and associated disordersVitamin D Research StudiesCeliac Disease Research and Management03 medical and health sciences0302 clinical medicineAge of OnsetAutoantibodiesAutoimmunityCase-Control StudiesCaseinsChildChild, PreschoolDiabetes Mellitus, Type 1FemaleGenetic Predisposition to DiseaseHistocompatibility TestingHumansInfantInfant FormulaInfant Nutritional Physiological PhenomenaIslets of LangerhansMaleNutritional StatusRisk FactorsVitamin D

MeSH Terms

AutoantibodiesCaseinsChildChild, PreschoolDiabetes Mellitus, Type 1FemaleHistocompatibility TestingHumansInfantInfant Nutritional Physiological PhenomenaIslets of LangerhansMaleNutritional StatusRisk FactorsVitamin DAutoimmunityCase-Control StudiesAge of OnsetGenetic Predisposition to DiseaseInfant Formula

Keywords

IsletMedicineAutoimmunityType 1 diabetesNested case-control studyHuman physiologyDiabetes mellitusInternal medicineType 2 diabetesCase-control studyEndocrinologyDiseaseVitamin D25-hydroxyvitamin DIslet AutoimmunityMaleNutritional StatusVITAMIN-D STATUSArticleIslets of LangerhansHYDROLYZED INFANT FORMULARisk FactorsHumansGenetic Predisposition to DiseaseAge of OnsetChildInfant Nutritional Physiological PhenomenaAutoantibodiesHistocompatibility TestingCaseinsInfantGeneral medicine, internal medicine and other clinical medicineInfant FormulaPREGNANCYDiabetes Mellitus, Type 1Case-Control StudiesChild, PreschoolFemale

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being